* Names, CVs (as available), locations and contact details are available to Subscribers. To subscribe, please contact Emma Taylor at email@example.com or 01423 727 724 for details on subscription costs.
Page No 1
the role of the p53/MDM2 pathway in radioresistance and cellular motility
Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery
Page No 1
Third Party Advertisement
Adverts by Google
Enter the description for this link and click ok or to close, click the close button or use the ESC key.